Veronica Jimenez

Dr. Veronica Jimenez

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in Research in Microbiology
Verified
Journal Article
Closed access
VJVeronica Jimenez
Veronica Jimenez

29 December 2022 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
VJVeronica Jimenez
Veronica Jimenez
SMSebastian Mesones
Sebastian Mesones
Parasitic diseases caused by protozoans are highly prevalent around the world, disproportionally affecting developing countries, where coinfection with other microorganisms is common. Control and treatment of parasitic infections are constrained by the lack of specific and effective drugs, plus the rapid emergence of resistance. Ion channels are main drug targets for numerous diseases, but their potential against protozoan parasites is still untapped. Ion channels are membrane proteins expressed in all types of cells, allowing for the flow of ions between compartments, and regulating cellular functions such as membrane potential, excitability, volume, signaling, and death. Channels and transporters reside at the interface between parasites and their hosts, controlling nutrient uptake, viability, replication, and infectivity. To understand how ion channels control protozoan parasites fate and to evaluate their suitability for therapeutics, we must deepen our knowledge of their structure, function, and modulation. However, methodological approaches commonly used in mammalian cells have proven difficult to apply in protozoans. This review focuses on ion channels described in protozoan parasites of clinical relevance, mainly apicomplexans and trypanosomatids, highlighting proteins for which molecular and functional evidence has been correlated with their physiological functions.

2 July 2021 in eLife
Verified
Journal Article
Open access
Noopur DaveNoopur Dave
Noopur Dave
UCUgur Cetiner
Ugur Cetiner
DADaniel Arroyo
Daniel Arroyo
JFJoshua Fonbuena
Joshua Fonbuena
MTMegna Tiwari
Megna Tiwari
VJVeronica Jimenez
Veronica Jimenez
The causative agent of Chagas disease undergoes drastic morphological and biochemical modifications as it passes between hosts and transitions from extracellular to intracellular stages. The osmotic and mechanical aspects of these cellular transformations are not understood. Here we identify and characterize a novel mechanosensitive channel in Trypanosoma cruzi (TcMscS) belonging to the superfamily of small-conductance mechanosensitive channels (MscS). TcMscS is activated by membrane tension and forms a large pore permeable to anions, cations, and small osmolytes. The channel changes its location from the contractile vacuole complex in epimastigotes to the plasma membrane as the parasites develop into intracellular amastigotes. TcMscS knockout parasites show significant fitness defects, including increased cell volume, calcium dysregulation, impaired differentiation, and a dramatic decrease in infectivity. Our work provides mechanistic insights into components supporting pathogen adaptation inside the host, thus opening the exploration of mechanosensation as a prerequisite for protozoan infectivity.

31 December 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
CFCalifornia State University Fullert
California State University Fullert
JMJesus Magallon
Jesus Magallon
KRKenneth Rocha
Kenneth Rocha
TTTran Tran
Tran Tran
KPKimberly Phan
Kimberly Phan
Marcelo TolmaskyMarcelo Tolmasky
Marcelo Tolmasky
Clinical resistance to amikacin and other aminoglycosides is usually due to the enzymatic acetylation of the antimicrobial molecule. A ubiquitous resistance enzyme among Gram-negatives is the aminoglycoside 6′-N-acetyltransferase type Ib [AAC(6′)-Ib], which catalyzes acetylation using acetyl-CoA as a donor substrate. Therapies that combine the antibiotic and an inhibitor of the inactivation reaction could be an alternative to treat infections caused by resistant bacteria. We previously observed that metal ions such as Zn2+ or Cu2+ in complex with ionophores interfere with the AAC(6′)-Ib-mediated inactivation of aminoglycosides and reduced resistance to susceptibility levels. Ag1+ recently attracted attention as a potentiator of aminoglycosides′ action by mechanisms still in discussion. We found that silver acetate is also a robust inhibitor of the enzymatic acetylation mediated by AAC(6′)-Ib in vitro. This action seems to be independent of other mechanisms, like increased production of reactive oxygen species and enhanced membrane permeability, proposed to explain the potentiation of the antibiotic effect by silver ions. The addition of this compound to aac(6′)-Ib harboring Acinetobacter baumannii and Escherichia coli cultures resulted in a dramatic reduction of the resistance levels. Time-kill assays showed that the combination of silver acetate and amikacin was bactericidal and exhibited low cytotoxicity to HEK293 cells.

16 August 2022 in Journal of Eukaryotic Microbiology
Verified
Journal Article
Closed access
VJVeronica Jimenez
Veronica Jimenez
KMKildare Miranda
Kildare Miranda
IAIngrid Augusto
Ingrid Augusto

1 May 2018 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
TTTung Tran
Tung Tran
KCKevin Chiem
Kevin Chiem
SJSaumya Jani
Saumya Jani
BABrock A. Arivett
Brock A. Arivett
DLDavid L. Lin
David L. Lin
Marcelo TolmaskyMarcelo Tolmasky
Marcelo Tolmasky